The research, published in October’s issue of the prestigious journal Social Science and Medicine, could lead the medical profession to rethink the way it communicates with patients who have these complexgenetic predispositions.
Lead author Dr Paula Saukko of Egenis says: ‘The way in which general practitioners and hospital consultants sometimes introduced the test and communicated its results was too informal and inconsistent seven out of the fortytwo participants did not know that they had had a genetic test for thrombophilia. People who were poorly aware of the potential risk could not take precautions or advice their family members about taking precautions, such as avoiding the Pill or hormone replacement therapy. Those people who were aware of having genetic thrombophilia had given up oestrogen containing medications but had typically not changed their lifestyle.
Thrombophilia receives much less public attention than breast cancer genetics, but it is the most common genetic test in the US and one of the most common in the UK. This is the first study examining the experiences of patients who had undergone genetic testing for thrombophilia in the UK.
The research found that there is a subgroup of patients with a poor understanding of their genetic predisposition to thrombophilia and of the genetic test. Among the participants for this study, this subgroup consisted of older women, mainly from lower social classes, who had poor health. The research team calls for the profession to ensure people with this genetic predisposition are better informed.
Ginny Russell | alfa
Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy